Mediterranean diet may reduce type 2 diabetes risk, biomarker study finds
By
Alicia Lasek
May 01, 2023
Adherence to the Mediterranean diet is linked to a lower risk of type 2 diabetes, according to a new study that used blood biomarkers to determine adherence.
Glucose-lowering meds compared for use with metformin in T2DM
Oct 03, 2022
Glargine, liraglutide modestly more effective for target glycated hemoglobin levels; microvascular outcomes do not differ materially
NIH: Two drugs most effective in treating type 2 diabetes
By
John Roszkowski
Sep 23, 2022
Two popular drugs used to treat type 2 diabetes outperformed other medications in managing glucose levels and keeping people with type 2 diabetes healthy, according to new research funded by the National...
7 healthy habits may reduce dementia risk for diabetics
By
Lori Baker
Sep 21, 2022
Affecting 1 in 10 adults, type 2 diabetes is a troubling condition that also increases a person’s risk of developing dementia. But a study published in the Sept. 14 online issue Neurology reveals that...
More exercise, healthy eating can prevent type 2 diabetes in older adults, study finds
By
John Roszkowski
May 24, 2022
Lifestyle changes such as increased physical activity and healthy eating aimed at reducing weight lost, combined with the anti-diabetic medication metformin, were effective in delaying or preventing type...
FDA approves diabetes drug with evidence of superior blood sugar control
By
Alicia Lasek (f3)
May 17, 2022
Mounjaro was more effective than other type 2 diabetes drugs at helping clinical trial participants control blood sugar and lose weight, the FDA reports.
Screen racial, ethnic groups at lower BMI levels for diabetes, researchers say
By
Alicia Lasek (f3)
May 13, 2022
A newly vetted set of BMI diagnosis thresholds can help clinicians catch diabetes earlier in higher risk groups, investigators say.
Subjective cognitive impairment linked to MACE in T2DM
Apr 26, 2022
Among individuals with type 2 diabetes, country-standardized cognitive score may predict risk for cardiovascular events
Frail heart failure patients improve with common diabetes drug, trial finds
By
Alicia Lasek (f3)
Apr 26, 2022
The SGLT2 inhibitor Farxiga substantially reduced risk for worsening heart failure events and death in frail patients, a new analysis finds. The more frail the patient, the more benefits seen.
Achieving treatment goals in T2DM can increase life expectancy
Apr 19, 2022
Life expectancy gains seen with reducing HbA1c, SBP, LDL-C, and BMI among individuals with type 2 diabetes
